About Vacuolar protein sorting-associated protein 4B
Vacuolar protein sorting-associated protein 4B (VPS4B) is a protein
from Homo sapiens identified by UniProt accession
O75351, 444 residues long.
MolForge cross-references it against 0 known binders and
91 disease associations.
Target properties
| Protein name | Vacuolar protein sorting-associated protein 4B |
| UniProt accession | O75351 |
| Gene | VPS4B |
| Organism | Homo sapiens |
| Length | 444 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (91)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.46
- dentin dysplasia type I · score 0.37
- monocyte percentage of leukocytes · score 0.22
- drug use measurement · score 0.10
- cancer · score 0.09
- reticulocyte measurement · score 0.06
- eosinophil count · score 0.05
- eosinophil percentage of leukocytes · score 0.04
- DNA methylation · score 0.04
- sex hormone-binding globulin measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75351-F1 | alphafold | PREDICTED | 85.92 | — |
Amino-acid sequence (444 residues)
MSSTSPNLQK AIDLASKAAQ EDKAGNYEEA LQLYQHAVQY FLHVVKYEAQ GDKAKQSIRA KCTEYLDRAE KLKEYLKNKE KKAQKPVKEG QPSPADEKGN DSDGEGESDD PEKKKLQNQL QGAIVIERPN VKWSDVAGLE GAKEALKEAV ILPIKFPHLF TGKRTPWRGI LLFGPPGTGK SYLAKAVATE ANNSTFFSIS SSDLVSKWLG ESEKLVKNLF QLARENKPSI IFIDEIDSLC GSRSENESEA ARRIKTEFLV QMQGVGVDND GILVLGATNI PWVLDSAIRR RFEKRIYIPL PEPHARAAMF KLHLGTTQNS LTEADFRELG RKTDGYSGAD ISIIVRDALM QPVRKVQSAT HFKKVRGPSR ADPNHLVDDL LTPCSPGDPG AIEMTWMDVP GDKLLEPVVS MSDMLRSLSN TKPTVNEHDL LKLKKFTEDF GQEG
Explore Vacuolar protein sorting-associated protein 4B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets